Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia

Background Hair loss may significantly impact an individual’s self-image, and studies indicate that patients with both clinically apparent and clinically imperceptible hair loss may have significantly decreased quality of life (QoL). Moreover, clinical severity of hair loss does not necessarily pred...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2012-03, Vol.66 (3), p.e97-e102
Main Authors: Reid, Erika Elise, BA, Haley, Ann Cameron, BA, Borovicka, Judy H., MD, Rademaker, Alfred, PhD, West, Dennis P., PhD, Colavincenzo, Maria, MD, Wickless, Heather, MD
Format: Article
Language:English
Subjects:
alopecia
Alopecia - pathology
Alopecia - psychology
alopecia areata
Alopecia Areata - pathology
Alopecia Areata - psychology
androgenic alopecia
Dermatology
Dermatology - standards
Female
Humans
Patients - psychology
Physical Examination - standards
Physicians - psychology
Predictive Value of Tests
Quality of Life
Self Concept
Self Report - standards
Severity of Illness Index
Skindex-16
Surveys and Questionnaires - standards
telogen effluvium
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Hair loss may significantly impact an individual’s self-image, and studies indicate that patients with both clinically apparent and clinically imperceptible hair loss may have significantly decreased quality of life (QoL). Moreover, clinical severity of hair loss does not necessarily predict impact on QoL. Objective The aim of this study was to assess QoL in patients (n = 104) with alopecia areata, telogen effluvium, and androgenic alopecia, and to compare QoL with hair loss severity (HLS) as independently rated by both patient and dermatologist. Methods Questionnaires and clinical assessment tools were used to assess HLS, and QoL was measured by completion of Skindex-16. Results Overall, patients rated their hair loss as more severe than the dermatologist, and the patient’s HLS rating more strongly correlated with QoL than the dermatologist’s rating. Clinical assessment of HLS did not reliably predict the patient’s QoL, nor did it predict the patient’s perception of HLS. Limitations A convenience sample was recruited from a referral clinic and Skindex-16 has not been validated for use in women’s alopecia disorders. Conclusion These findings indicate dermatologists should address these psychosocial and QoL issues when treating patients with alopecia.
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2010.11.042